Sei Investments Co. lifted its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Free Report) by 28.2% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 544,221 shares of the real estate investment trust’s stock after acquiring an additional 119,734 shares during the period. Sei Investments Co.’s holdings in Sabra Healthcare REIT were worth $10,465,000 at the end of the most recent reporting period.
Other institutional investors have also recently added to or reduced their stakes in the company. PNC Financial Services Group Inc. boosted its holdings in Sabra Healthcare REIT by 2.3% in the fourth quarter. PNC Financial Services Group Inc. now owns 23,807 shares of the real estate investment trust’s stock valued at $451,000 after purchasing an additional 528 shares in the last quarter. Larson Financial Group LLC raised its holdings in Sabra Healthcare REIT by 42.3% during the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock worth $35,000 after purchasing an additional 553 shares in the last quarter. Inspire Investing LLC raised its holdings in Sabra Healthcare REIT by 2.3% during the fourth quarter. Inspire Investing LLC now owns 24,747 shares of the real estate investment trust’s stock worth $469,000 after purchasing an additional 565 shares in the last quarter. Natixis Advisors LLC lifted its position in shares of Sabra Healthcare REIT by 2.2% during the 3rd quarter. Natixis Advisors LLC now owns 27,664 shares of the real estate investment trust’s stock worth $516,000 after buying an additional 598 shares during the last quarter. Finally, UMB Bank n.a. lifted its position in shares of Sabra Healthcare REIT by 28.3% during the 4th quarter. UMB Bank n.a. now owns 3,065 shares of the real estate investment trust’s stock worth $58,000 after buying an additional 676 shares during the last quarter. Hedge funds and other institutional investors own 99.40% of the company’s stock.
Analyst Upgrades and Downgrades
Several research analysts have recently issued reports on the stock. Barclays assumed coverage on shares of Sabra Healthcare REIT in a report on Tuesday, July 7th. They issued an “overweight” rating and a $21.00 target price for the company. Raymond James Financial started coverage on shares of Sabra Healthcare REIT in a research note on Wednesday, June 17th. They set an “underperform” rating on the stock. Cantor Fitzgerald boosted their price target on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a research report on Monday, May 11th. Wall Street Zen upgraded shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research note on Sunday, June 28th. Finally, Citizens Jmp raised their price objective on Sabra Healthcare REIT from $23.00 to $25.00 and gave the stock a “market outperform” rating in a report on Wednesday, July 22nd. Eight investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $22.25.
Sabra Healthcare REIT Price Performance
Shares of NASDAQ SBRA opened at $21.17 on Friday. The company has a current ratio of 4.72, a quick ratio of 4.72 and a debt-to-equity ratio of 0.96. Sabra Healthcare REIT, Inc. has a twelve month low of $17.17 and a twelve month high of $22.77. The stock has a 50 day moving average of $19.77 and a two-hundred day moving average of $19.92. The stock has a market cap of $5.34 billion, a P/E ratio of 33.60, a P/E/G ratio of 1.64 and a beta of 0.65.
Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last announced its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.16. The business had revenue of $211.74 million for the quarter, compared to analyst estimates of $209.20 million. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The company’s revenue for the quarter was up 20.9% compared to the same quarter last year. During the same period last year, the firm posted $0.37 earnings per share. On average, research analysts forecast that Sabra Healthcare REIT, Inc. will post 1.51 earnings per share for the current year.
Sabra Healthcare REIT Company Profile
Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net?lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long?term, triple?net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.
Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post?acute rehabilitation and research and development laboratories.
Recommended Stories
- Five stocks we like better than Sabra Healthcare REIT
- Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Free Report).
Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
